New blood test offers breakthrough in myeloma diagnosis and monitoring
A Blood Test Revolution: How SWIFT-seq Could Change Multiple Myeloma Diagnosis For years, patients battling multiple myeloma have faced the daunting prospect of frequent bone marrow biopsies – a painful and often inconclusive procedure. But a groundbreaking new blood test, dubbed SWIFT-seq, developed by researchers at the Dana-Farber Cancer Institute, promises a paradigm shift in … Read more